Fosdesdenosine sipalabenamide is an investigational new drug that is being evaluated for the treatment of advanced solid tumors and lymphoma. This compound is a phosphoramidate derivative of cordycepin (3'-deoxyadenosine), a chemical compound originally isolated from the fungus Cordyceps militaris. As a nucleoside analog with potential antineoplastic properties, Fosdesdenosine sipalabenamide is designed to inhibit RNA synthesis and act as an RNA inhibitor. The drug is being developed by NuCana Plc.
References